Literature DB >> 6611487

Isolation and biochemical characterization of the H-2Kk and H-2Dk antigens from the RDM-4 lymphoma.

S B Cohen, J E Coligan, J H Freed.   

Abstract

Milligram amounts of the H-2Kk and H-2Dk antigens from the RDM-4 lymphoma have been isolated in a one-step procedure employing affinity chromatography on monoclonal antibodies conjugated to Sepharose. The purified antigens have been characterized biochemically, including amino-terminal amino acid sequence and tryptic peptide analyses of the 45,000 mol. wt chains of the antigens. The amino acid sequence results for the H-2Kk antigen, when compared with previously reported data for this molecule, reveal a discrepancy in the sequence of this 45,000 mol. wt chain. We postulate that this discrepancy reflects a previously undescribed polymorphism for the Kk-gene. We also report the first amino-terminal amino acid sequence for the 45,000 mol. wt chain from the H-2Dk antigen and demonstrate that the sequence of the beta 2-microglobulin obtained from the H-2Kk antigen preparation is identical to that published previously. Finally, the structural integrity of the H-2Kk antigen is assessed using binding of beta 2-microglobulin, incorporation into liposomes and reaction with antibodies as criteria.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6611487     DOI: 10.1016/0161-5890(84)90060-9

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  2 in total

1.  Murine T lymphocytes and T-lymphoma cells produce chondroitin sulphate and heparan sulphate proteoglycans and free heparan sulphate glycosaminoglycan.

Authors:  A P Wilson; C C Rider
Journal:  Immunology       Date:  1991-01       Impact factor: 7.397

2.  Intracellular transport of membrane glycoproteins: two closely related histocompatibility antigens differ in their rates of transit to the cell surface.

Authors:  D B Williams; S J Swiedler; G W Hart
Journal:  J Cell Biol       Date:  1985-09       Impact factor: 10.539

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.